Fluorescence in situ hybridization: Uses and limitations

Seminars in Hematology

Volumn 37, Issue 4, 2000, Pages 320-333

  Gozzetti, Alessandro ^a   Le Beau, Michelle M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DISEASE; CANCER CLASSIFICATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME IDENTIFICATION; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MONITORING; PRIORITY JOURNAL;

EID: 0033794572     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90013-1     Document Type: Conference Paper

References (59)

1. A complete set of human telomeric probes and their clinical application. National Institutes of Health and Institute of Molecular Medicine collaboration
2. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: A simple and sensitive method
3. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization
4. Fish analysis at diagnosis in acute lymphoblastic leukemia
5. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
6. Total therapy with tandem transplants for newly diagnosed multiple myeloma
7. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization
8. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma
9. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations
10. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
11. Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome specific library probes
12. Deletion of the retinoblastoma gene in multiple myeloma
13. The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL
14. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia
15. Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications
16. p53 Gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
17. Chromosome aberrations in B-cell chronic lymphocytic leukemia: Reassessment based on molecular cytogenetic analysis
18. 11q Deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
19. Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy
20. Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization
21. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia
22. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia
23. Cytogenetic abnormalities in multiple myeloma
24. Interphase cytogenetics in chronic lymphocytic leukemia
25. Multiple myeloma: Increasing evidence for a multistep transformation process
26. Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia
27. Interphase fluorescence in situ hybridization: A sensitive method for trisomy 8 detection in bone marrow specimens
28. High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells
29. Cytogenetics in chronic lymphocytic leukemia
30. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia
31. The impact of the new FISH technologies on the cytogenetics of haematological malignancies
32. 2-Acetylaminofluorene-modified probes for the indirect hybridocytochemical detection of specific nucleic acid sequences
33. Enzymatic synthesis of biotin labeled polynucleotides: Novel nucleic acid affinity probes
34. Heterogeneity in telomere length of human chromosomes
35. Molecular biology of cancer: Cytogenetics
36. Fluorescence in situ hybridization in cancer diagnosis
37. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization
38. Look AT: Oncogenic transcription factors in the human acute leukemias
39. BCL3 rearrangements and t(14,19) in chronic lymphocytic leukemia and other B-cell malignancies: A molecular and cytogenetic study
40. Catalog of Chromosome Aberrations in Cancer
41. Multiple fluorescence in situ hybridization
42. Padlock probes reveal single nucleotide differences, parent of origin and in situ distribution of centromeric sequences in human chromosomes 13 and 21
43. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization
44. Genetics of small lymphocyte disorders
45. Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes
46. Fluorescence in situ hybridization with human chromosome specific libraries: Detection of trisomy 21 and translocation of chromosome 4
47. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization
48. Interphase cytogenetics of hematological cancer: Comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes
49. Two 22q telomere deletions serendipitously detected by FISH
50. Fluorescence in situ hybridization: Molecular probes for diagnosis of pediatric neoplastic diseases
51. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
52. Molecular analysis of 11q13 breakpoints in multiple myeloma
53. Improved sensitivity of BCR-ABL detection: A triple probe three-color fluorescence in situ hybridization system
54. The prognostic significance of 13q14 deletions in chronic lymphocytic leukemia
55. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization
56. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities
57. Several subclones may be identified within plasma cells of patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of the condition
58. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by fluorescence in situ hybridization